Coskun Ozer Demirtas
Overview
Explore the profile of Coskun Ozer Demirtas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kani H, Demirtas C, Keklikkiran C, Ergenc I, Mehdiyev S, Akdeniz E, et al.
Turk J Gastroenterol
. 2021 Sep;
32(8):661-666.
PMID: 34528879
Background: Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated fatty liver disease (MAFLD) is still not clear...
22.
Demirtas C, Keklikkiran C, Ergenc I, Erturk Sengel B, Eskidemir G, Cinel I, et al.
Int J Clin Pract
. 2021 May;
75(9):e14363.
PMID: 33993597
Background: Pre-existing chronic liver disease is currently considered a poor prognostic factor for coronavirus disease 2019 (COVID-19). The present study aimed to investigate the association of liver stiffness measurement (LSM)...
23.
Demirtas C, Yilmaz Y
Aliment Pharmacol Ther
. 2021 May;
53(11):1228-1229.
PMID: 33961704
No abstract available.
24.
Demirtas C, Keklikkiran C, Mehdiyev S, Ergenc I, Ozen Alahdab Y, Gunduz F, et al.
Turk J Gastroenterol
. 2021 May;
32(2):113-115.
PMID: 33960933
In the midst of Coronavirus-19 (COVID-19) pandemic, endoscopic procedures have been separated for only urgent and semi-urgent cases for the last few months to prevent transmission in endoscopy units. This...
25.
Colombatto P, Demirtas C, Ricco G, Civitano L, Boraschi P, Scalise P, et al.
Cancers (Basel)
. 2021 Apr;
13(9).
PMID: 33922938
In advanced HCC, tyrosine-kinase inhibitors obtain partial responses (PR) in some patients and complete responses (CR) in a few. Better understanding of the mechanism of response could be achieved by...
26.
Demirtas C, Gunduz F
Aliment Pharmacol Ther
. 2020 Nov;
52(11-12):1765-1766.
PMID: 33205876
No abstract available.
27.
Bicakci E, Demirtas C, Celikel C, Haklar G, Duman D
Turk J Gastroenterol
. 2020 Nov;
31(10):681-687.
PMID: 33169705
Background/aims: Specific serum markers reflecting hepatic inflammation and fibrosis are required to tailor the treatment strategies in non-alcoholic steatohepatitis (NASH). We aimed to investigate the roles of myeloperoxidase (MPO) and...
28.
Fatih Demirci A, Demirtas C, Eren F, Yilmaz D, Keklikkiran C, Ozdogan O, et al.
J Gastrointestin Liver Dis
. 2020 Oct;
29(4):617-622.
PMID: 33118543
Background And Aims: Programmed cell death-1 (PD-1) has a vital role in regulating T-cell function, and immune escape mechanism of cancer cells. It was shown that there could be a...
29.
Kani H, Ergenc I, Arikan H, Komesli Z, Seyrek B, Demirtas C, et al.
Turk J Gastroenterol
. 2020 Sep;
31(8):566-572.
PMID: 32915144
Background/aims: Inflammatory bowel diseases (IBD) impairs patients' quality of life (QoL). Inflammatory bowel disease questionnaire (IBDQ) is created to measure the health-related QoL specific for IBD. We planned to investigate...
30.
Demirtas C, Ata P, Cetin A, Turkyilmaz A, Duman D
Turk J Gastroenterol
. 2020 Sep;
31(7):508-514.
PMID: 32897224
Background And Aims: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome characterized by tumors arising from endocrine glands with no specific genotype-phenotype correlation. Herein, we report the...